New York Life Investment Management LLC Has $7.50 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

New York Life Investment Management LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 25,002 shares of the company’s stock after selling 135 shares during the quarter. New York Life Investment Management LLC’s holdings in HCA Healthcare were worth $7,504,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $31,000. National Pension Service grew its stake in shares of HCA Healthcare by 3.6% in the 4th quarter. National Pension Service now owns 570,291 shares of the company’s stock valued at $171,173,000 after buying an additional 19,637 shares in the last quarter. Denali Advisors LLC grew its stake in shares of HCA Healthcare by 78.6% in the 4th quarter. Denali Advisors LLC now owns 2,500 shares of the company’s stock valued at $750,000 after buying an additional 1,100 shares in the last quarter. Todd Asset Management LLC grew its stake in shares of HCA Healthcare by 1.7% in the 4th quarter. Todd Asset Management LLC now owns 136,917 shares of the company’s stock valued at $41,096,000 after buying an additional 2,348 shares in the last quarter. Finally, Keeler Thomas Management LLC bought a new stake in HCA Healthcare during the fourth quarter worth approximately $797,000. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on HCA. Morgan Stanley decreased their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Royal Bank of Canada decreased their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Finally, Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $305.79 on Friday. The business has a fifty day simple moving average of $315.15 and a 200 day simple moving average of $349.52. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $75.94 billion, a price-to-earnings ratio of 13.92, a PEG ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company earned $5.90 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.94%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.